| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| L-Carnitine | Dyslipidemia | 5 | PM | 37727632 | 📋 | The effect of L-carnitine supplementation on lipid profile in adults: an umbrella meta-analysis on interventional meta-analyses |
| L-Carnitine | Dyslipidemia | 4 | PM | 34999386 | 📋 | Comprehensive assessment of the effectiveness of l-carnitine and transresveratrol in rats with diet-induced obesity |
| L-Carnitine | Dyslipidemia | 3 | PM | 33510873 | 📋 | The effects of L-carnitine supplementation on lipid concentrations inpatients with type 2 diabetes: A systematic review and meta-analysis of randomized clinical trials |
| L-Carnitine | Dyslipidemia | 1 | PM | 32676462 | 📋 | Effect of L-Carnitine Supplementation on Lipid Profiles of Patients with Liver Disease: A Systematic Review and Meta-Analysis |
| L-Carnitine | Dyslipidemia | 2 | PM | 18850230 | 📋 | A mixture of the aqueous extract of Garcinia cambogia, soy peptide and L: -carnitine reduces the accumulation of visceral fat mass in rats rendered obese by a high fat diet |
| L-Carnitine | HDL Low | 1 | PM | 2636667 | 📋 | Effect of low dose supplementation of L-carnitine on lipid metabolism in hemodialyzed children |
| L-Carnitine | Hematologic Disorders | 1 | PM | 35293664 | 📋 | Artemisinin and l-carnitine combination therapy alters the erythrocytes redox status |
| L-Carnitine | Hyperammonemia | 8 | PM | 36740101 | 📋 | Quantitative Systems Pharmacology Model to Characterize Valproic Acid-induced Hyperammonemia and the Effect of L-Carnitine Supplementation |
| L-Carnitine | Hyperammonemia | 1 | PM | 32925502 | 📋 | L-carnitine reduces hospital admissions in patients with hepatic encephalopathy |
| L-Carnitine | Hyperammonemia | 2 | PM | 16445703 | 📋 | Effects of a single, short intravenous dose of acetyl-L-carnitine on pattern-reversal visual-evoked potentials in cirrhotic patients with hepatic encephalopathy |
| L-Carnitine | Hyperammonemia | 4 | PM | 9049197 | 📋 | Protective effect of L-carnitine in ammonia-precipitated encephalopathy in the portacaval shunted rat |
| L-Carnitine | Hyperammonemia | 5 | PM | 6462327 | 📋 | Prevention of ammonia toxicity by L-carnitine: metabolic changes in brain |
| L-Carnitine | Hyperammonemia | 6 | PM | 3663232 | 📋 | Effect of L-carnitine on ketone bodies, redox state and free amino acids in the liver of hyperammonemic mice |
| L-Carnitine | Hyperammonemia | 7 | PM | 2807161 | 📋 | Effect of orally administered L-carnitine on blood ammonia and L-carnitine concentrations in portacaval-shunted rats |
| L-Carnitine | Hyperammonemia | 3 | PM | 2103686 | 📋 | New roles of carnitine metabolism in ammonia cytotoxicity |
| L-Carnitine | Hypercholesterolemia | 1 | PM | 12867219 | 📋 | The effect of L-carnitine on plasma lipoprotein(a) levels in hypercholesterolemic patients with type 2 diabetes mellitus |
| L-Carnitine | Hyperlipidemia | 1 | PM | 34037885 | 📋 | Effect of L-carnitine supplementation on lipid profile and apolipoproteins in children on hemodialysis: a randomized placebo-controlled clinical trial |
| L-Carnitine | Lipoprotein(a) High | 3 | PM | 19618992 | 📋 | Effects of simvastatin and carnitine versus simvastatin on lipoprotein(a) and apoprotein(a) in type 2 diabetes mellitus |
| L-Carnitine | Lipoprotein(a) High | 1 | PM | 16384561 | 📋 | Efficacy and tolerability of combined treatment with L-carnitine and simvastatin in lowering lipoprotein(a) serum levels in patients with type 2 diabetes mellitus |
| L-Carnitine | Lipoprotein(a) High | 2 | PM | 12867219 | 📋 | The effect of L-carnitine on plasma lipoprotein(a) levels in hypercholesterolemic patients with type 2 diabetes mellitus |
